×

CNBC's R&D all-stars: Salix Pharmaceuticals and Vertex

2:26 PM ET Wed, 6 Aug 2014

CNBC's Dominic Chu looks at how well Salix Pharmaceuticals and Vertex allocate spending on research and developmental capital.